The sharp Q2 guidance deceleration (6-14% vs 33.8% in Q1) combined with persistent losses and rising short-term debt signals deteriorating fundamentals. Monitor the Q2 earnings report for actual revenue and cash burn; the $87M in short-term borrowings against $103M cash leaves minimal liquidity buffer. The HYROX global partnership and new product launches are positive but insufficient to offset the deceleration and cash drain.
Price Chart
Executive Summary
Zepp Health reported Q1 2026 revenue of $51.5M (+33.8% YoY), in line with guidance, with gross margin expanding to 37.7% (+0.4pp YoY). However, the company remained deeply unprofitable with a GAAP net loss of $19.6M (essentially flat YoY) and guided Q2 2026 revenue growth of only 6-14% YoY, a sharp deceleration from Q1's 33.8% growth. Cash burn continued ($9.7M QoQ decline) and short-term debt increased $31.2M QoQ, raising liquidity concerns for this $91M market cap company.
Key Facts
- Q1 2026 revenue $51.5M, +33.8% YoY (in line with guidance)
- GAAP net loss $19.6M, essentially flat vs $19.7M YoY loss
- Adjusted net loss $17.9M, nearly flat vs $18.1M YoY
- Q2 2026 guidance: $63-68M revenue, implying only 6-14% YoY growth — sharp deceleration
- Cash & equivalents $103.2M, down $9.7M from Q4 2025
- Short-term bank borrowings surged to $87.0M from $55.7M QoQ (+$31.2M)
- Operating loss narrowed slightly to $17.7M from $18.4M YoY
- Gross margin 37.7%, up from 37.3% YoY but down from 40.4% in Q4 2025
- Cumulatively retired $46.4M of debt since 2023; $3M remaining on $20M buyback authorization
Financial Impact
Revenue growth decelerating from 33.8% to ~6-14%; net loss persistent at ~$19.6M/quarter; cash burn $9.7M/quarter; short-term debt up $31.2M QoQ
Risk Factors
- Revenue growth decelerating sharply from 33.8% to 6-14% in Q2 guidance
- Persistent net losses with no path to profitability disclosed
- Cash burn of $9.7M/quarter; short-term debt surged $31.2M QoQ to $87.0M
- Gross margin declining sequentially from 40.4% to 37.7% due to entry-level product mix and component costs
- Foreign currency headwinds from RMB appreciation pressuring reported USD expenses
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001104659-26-071539 |
| Document: tm2617238d1_6k.htm | 0001104659-26-071539 |
| Document: 0001104659-26-071539-index-headers.html | 0001104659-26-071539 |
| Document: 0001104659-26-071539-index.html | 0001104659-26-071539 |
| Document: 0001104659-26-071539.txt | 0001104659-26-071539 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 2, 2026 7w ago | 6-K | $4.86 $4.51 | ▲ +7.20% | ▲ +8.25% | $2.54 (+47.74%) |
Sep 1, 2026 7w ago | Press Release | $4.86 $4.51 | ▲ +7.20% | ▲ +8.25% | $2.54 (+47.74%) |
Jun 11, 2026 19w ago | Institutional Cluster | $4.85 $4.69 | ▼ −3.30% | ▼ −3.84% | $2.54 (−47.63%) |
Jun 9, 2026 19w ago | 6-K | $4.41 $3.99 | ▲ +9.52% | ▲ +7.95% | $2.54 (+42.40%) |
Apr 24, 2026 26w ago | 20-F | $16.76 $16.89 | ▲ +0.78% | ▲ +0.61% | $2.54 (−84.84%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers